New glioblastoma vaccine shows promising results in phase Ib clinical trial
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial. (PHILADELPHIA) ...
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial. (PHILADELPHIA) ...
Study results to be presented during a plenary session at AACR Annual Meeting ATLANTA - A new combination of immunotherapy ...
ATLANTA --Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk than excess weight at ...
Computational tools seek to identify pancreatic cancer earlier, provide more opportunities for timely, effective treatmentsCredit: Pancreatic Cancer Collective (ATLANTA - ...
Credit: Hope Foundation for Cancer Research A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to ...
ATLANTA -- Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who ...
ATLANTA -- A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit among ...
ATLANTA -- A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was ...
ATLANTA -- A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity ...
ORLANDO, Fla., March 31, 2019 -- As current antibiotics dwindle in effectiveness against multidrug-resistant pathogens, researchers are seeking potential replacements ...
LAWRENCE -- A study to be published Monday in the Proceedings of the National Academy of Sciences offers a scientific ...
A Columbia-led study finds adversity-induced disruptions in the body's gut microbes influence are linked to changes in brain function A ...
Credit: Mount Sinai Health System The Mount Sinai Health System (MSHS) and the Hasso Plattner Institute (HPI) today announced an ...
XSEDE allocations on Stampede2 and Comet speed simulation of protein oligomersCredit: Taylor et al. Red blood cells are amazing. They ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.